RA Capital Healthcare Fund LP, Director, 10% Owner at Cytek Biosciences, Inc. (CTKB), bought 1,167,740 shares at $12.27 ($14.4M) on 2022-03-15, disclosed to the SEC on 2022-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.35 | 342,143 | $4.2M | 29.4% |
| 2 | $12.35 | 342,143 | $4.2M | 29.4% |
| 3 | $12.27 | 241,727 | $3.0M | 20.6% |
| 4 | $12.27 | 241,727 | $3.0M | 20.6% |
| Total | $12.32 avg | 1,167,740 | $14.4M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |